BUTYROLACTONE
House Bill 4783
Sponsor: Rep. Jennifer Faunce
Committee: Health Policy
Complete to 8-6-99
A SUMMARY OF HOUSE BILL 4783 AS INTRODUCED 6-11-99
The bill would amend the Public Health Code to list gamma-butyrolactone as a schedule 3 controlled substance.
Following federal law, the Public Health Code classifies controlled substances under one of four "schedules." Scheduled drugs must have the potential for abuse where, in general, the abuse is associated with a stimulant or depressive effect on the central nervous system and are either (a) illegal and without any medically accepted use in the United States (all schedule 1 drugs), or (b) prescription drugs with medically accepted uses in the United States that have a potential for psychological or physical dependence in addition to the potential for abuse (schedules 2, 3, and 4). Schedule 3 includes any substance with any quantity of a derivative of barbituric acid and drugs containing limited quantities of codeine, opium, or morphine.
MCL 333.7216
Analyst: S. Stutzky